Risk Assessment Spurs Early HER2-Positive Diagnosis for Olivia Munn’s Mother
Prompted by a 26.2 percent Tyrer-Cuzick lifetime risk score, Kim Munn underwent MRI screening that revealed Stage 1 HER2-positive breast cancer, leading to a double mastectomy, chemotherapy, Herceptin infusions through fall.
